oxaprozin has been researched along with Respiratory Tract Infections in 1 studies
Oxaprozin: An oxazole-propionic acid derivative, cyclooxygenase inhibitor, and non-steroidal anti-inflammatory drug that is used in the treatment of pain and inflammation associated with of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; and ARTHRITIS, JUVENILE.
oxaprozin : A monocarboxylic acid that is a propionic acid derivative having a 4,5-diphenyl-1,3-oxazol-2-yl substituent at position 3. It is non-steroidal anti-inflammatory drug commonly used to relieve the pain and inflammatory responses associated with osteoarthritis and rheumatoid arthritis.
Respiratory Tract Infections: Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Matsumoto, K | 1 |
Fujimori, I | 1 |
Tsubura, E | 1 |
Sakuma, A | 1 |
Hayashi, M | 1 |
Kudo, K | 1 |
Kimura, H | 1 |
Kono, M | 1 |
Sekita, T | 1 |
Takeda, Y | 1 |
1 trial available for oxaprozin and Respiratory Tract Infections
Article | Year |
---|---|
[Clinical evaluation of oxaprozin in the treatment of acute upper respiratory tract inflammations--a double-blind comparative study using ibuprofen as the control drug].
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Clinical Trials as Topic; Double-Blind Method; Female; | 1984 |